Skip to main content
. 2020 Jul 7;3(5):215–218. doi: 10.1002/iju5.12195

Fig. 1.

Fig. 1

Course of treatment. Nivolumab was initiated in December 2016. In August 2017, subcutaneous and lung metastases were observed. Moreover in January 2018, right renal metastasis was noted. After 22 cycles of nivolumab treatment, metastasis in the iliac bone was observed in April 2018. In May 2018, the patient was subjected to conventional palliative EBRT.